Literature DB >> 9125489

Hypertensive cardiomegaly caused by an aldosterone-secreting adenoma in a newborn.

G B Pozzan1, D Armanini, G Cecchetto, G Opocher, F Rigon, A Fassina, F Zacchello.   

Abstract

A case of primary hyperaldosteronism and cardiomegaly due to a unilateral adrenal adenoma in a newborn is presented. Some peculiarities, most likely in relation to the onset of the disease during fetal life were evident: plasma cortisol was slightly increased before surgery, plasma renin activity was elevated 9 months after surgery and mineralcorticoid receptors remained suppressed 4 months after surgery. Unilateral adrenalectomy reversed both hypertension and cardiomegaly. We speculate that cardiomegaly was related to both hyperaldosteronism and hypertension and that individual factors are involved in the pathogenesis of cardiomegaly in hyperaldosteronism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9125489     DOI: 10.1007/BF03347982

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  8 in total

1.  PRIMARY ALDOSTERONISM DUE TO AN ADRENAL ADENOMA IN A THREE-YEAR-OLD CHILD.

Authors:  B CAVELL; B HOEKFELT
Journal:  Acta Paediatr       Date:  1964-05       Impact factor: 2.299

Review 2.  CLINICAL CHARACTERISTICS OF PRIMARY ALDOSTERONISM FROM AN ANALYSIS OF 145 CASES.

Authors:  J W CONN; R F KNOPF; R M NESBIT
Journal:  Am J Surg       Date:  1964-01       Impact factor: 2.565

3.  Aldosterone-producing adrenal adenoma in children.

Authors:  S Etker; E A Enger
Journal:  Eur J Pediatr Surg       Date:  1992-12       Impact factor: 2.191

4.  Transplacental passage and fetal secretion of aldosterone.

Authors:  F Bayard; I G Ances; A J Tapper; V V Weldon; A Kowarski; C J Migeon
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

5.  Aldosterone receptors in different types of primary hyperaldosteronism.

Authors:  D Armanini; H Witzgall; M Wehling; U Kuhnle; P C Weber
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

6.  Characterization of aldosterone binding sites in circulating human mononuclear leukocytes.

Authors:  D Armanini; T Strasser; P C Weber
Journal:  Am J Physiol       Date:  1985-03

Review 7.  Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.

Authors:  K T Weber; C G Brilla
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

8.  Mineralocorticoid effector mechanism in preeclampsia.

Authors:  D Armanini; C M Zennaro; L Martella; M Scali; C Pratesi; P V Grella; F Mantero
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

  8 in total
  5 in total

1.  Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.

Authors:  J C Xiu; P Wu; J P Xu; Z Guo; W Lai; Y Zhang; S Li; J Li; Y Liu
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

2.  Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.

Authors:  D Armanini; C Scaroni; M J Mattarello; C Fiore; N Albiger; P Sartorato
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

Review 3.  Hypertension in infancy: diagnosis, management and outcome.

Authors:  Janis M Dionne; Carolyn L Abitbol; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-01-22       Impact factor: 3.714

4.  Antenatal and postnatal risk factors for neonatal hypertension and infant follow-up.

Authors:  Wael A Seliem; Michael C Falk; Bruce Shadbolt; Alison L Kent
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

5.  Some considerations about evolution of idiopathic primary aldosteronism.

Authors:  D Armanini; C Fiore
Journal:  J Endocrinol Invest       Date:  2009-07       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.